BCP15692
CAS NO. 1194506-26-7
英文品名 Fruquintinib
中文品名 呋喹替尼
分子式 C21H19N3O5
分子量 393.39
規(guī)格/純度 98%
供應(yīng)能力 can supply g scale
別名 HMPL-013;HMPL013;HMPL 013
產(chǎn)品簡(jiǎn)述 Fruquintinib (HMPL-013) inhibits VEGFR family member (VEGFR1, 2, 3) with IC50s of 33 nM, 35 nM and 0.5 nM, respectively with weak inhibition of RET, FGFR-1 and c-kit kinases.
詳細(xì)說(shuō)明 in vitro: Fruquintinib (HMPL-013) is a potent and highly selective small molecule inhibitor of VEGFR 1, 2, 3 tyrosine kinases for cancer therapy. Fruquintinib inhibits VEGFR2 (KDR) with an IC50 of 25 nM in the Z-lyte assay. Fruquintinib suppresses VEGF/VEGFR signaling and cell proliferation in HUVECs and HLECs. Fruquintinib inhibits tubule sprouting and prevents angiogenesis. in vivo: Fruquintinib potently inhibits VEGF induced KDR phosphorylation in lung tissue of mouse. Fruquintinib inhibits tumor growth in multiple human xenograft models.